Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Tirzepatide came off the FDAs official drug shortage list in December 2024, and semaglutide followed in February 2025, eliminating the legal pathway that allowed compounding pharmacies to produce copies of the drugs
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
Some individuals may experience: Mild injection site irritation or warmth Temporary flushing or tingling Nausea or lightheadedness Rare headache or fatigue Most side effects are mild and transient
That's why The Absorption Company is changing the conversation because if your body can't absorb it, it can't use it
The compounding market includes companies like telehealth business Hims & Hers, which are selling GLP-1s made from similar ingredients but arent branded, FDA-approved drugs
For individuals who cannot afford pharmaceutical products, compounded options provide access
US$ 24.26
US$ 25.34
US$ 22.64
US$ 24.87
